Page last updated: 2024-08-21

quinazolines and Hypomelanosis

quinazolines has been researched along with Hypomelanosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasegawa, J; Katayama, I; Tanemura, A; Tsuruta, D; Wataya-Kaneda, M; Yang, F; Yang, L; Yoshimori, T	1

Other Studies

1 other study(ies) available for quinazolines and Hypomelanosis

Article	Year
Dysregulation of autophagy in melanocytes contributes to hypopigmented macules in tuberous sclerosis complex. Journal of dermatological science, 2018, Volume: 89, Issue:2 Topics: Allyl Compounds; Autophagy; Epidermal Cells; Epidermis; Gene Knockdown Techniques; Humans; Hypopigmentation; Immunosuppressive Agents; Macrolides; Melanins; Melanocytes; Microscopy, Electron; Microtubule-Associated Proteins; Primary Cell Culture; Quinazolines; RNA, Small Interfering; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins	2018

Article

Year

Dysregulation of autophagy in melanocytes contributes to hypopigmented macules in tuberous sclerosis complex.

Journal of dermatological science, 2018, Volume: 89, Issue:2

Topics: Allyl Compounds; Autophagy; Epidermal Cells; Epidermis; Gene Knockdown Techniques; Humans; Hypopigmentation; Immunosuppressive Agents; Macrolides; Melanins; Melanocytes; Microscopy, Electron; Microtubule-Associated Proteins; Primary Cell Culture; Quinazolines; RNA, Small Interfering; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins

2018